Ontology highlight
ABSTRACT: Importance
Although small intestinal adenocarcinomas (SIAs) are rare, they have a poor prognosis, and the optimal treatment strategies are largely unknown. Because of the lack of high-quality evidence, guidelines for colorectal cancer are often followed in the treatment of SIAs.Objective
To review the current evidence regarding survival benefit of systemic therapies, including chemotherapy, targeted agents, and immunotherapy, for patients with SIAs.Data sources
Following the Preferred Reporting Items for Systematic Reviews and Meta-analyses, MEDLINE and Embase were searched for articles published from January 1, 2005, until June 1, 2022.Study selection
Retrospective cohort studies and prospective phase 2 or 3 trials describing survival after systemic therapi
SUBMITTER: de Back T
PROVIDER: S-EPMC9958532 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature